Track Progyny, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Progyny, Inc. PGNY Open Progyny, Inc. in new tab

16.60 USD
P/E
25.54
EPS
0.65
P/B
2.66
ROE
12.48
Beta
0.99
Target Price
27.45 USD
Progyny, Inc. logo

Progyny, Inc.

🧾 Earnings Recap – Q3 2025

Progyny reported strong Q3 results, exceeding revenue and profitability guidance while significantly expanding its client base, resulting in a quarterly revenue guidance increase of over $70 million.

  • Q3 revenue and adjusted EBITDA surpassed expectations, leading to raised full-year guidance for the third consecutive quarter.
  • Acquired over 80 new logos and 900,000 covered lives during the recent selling season, demonstrating strong demand for family-building and women's health solutions.
  • Achieved nearly 100% renewal rate of existing clients and expanded benefits for nearly 30% of clients for 2026, validating market leadership.
  • New services in pregnancy postpartum and menopause have gained notable traction, adding access for 2.7 million members next year.
  • White House initiative to expand access to fertility care represents a positive outlook for Progyny, especially in the small and midsized employer market.
📅
Loading chart...
Key Metrics
Earnings dateMay 6, 2026
P/E25.54
EPS0.65
Book Value6.24
Price to Book2.66
Debt/Equity5.37
% Insiders1.846%
Growth
Revenue Growth0.07%
Earnings Growth0.21%
Estimates
Forward P/E7.90
Forward EPS2.10
Target Mean Price27.45

DCF Valuation

Tweak assumptions to recompute fair value for Progyny, Inc. (PGNY)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Progyny, Inc. Logo Progyny, Inc. Analysis (PGNY)

United States Health Care Official Website Stock

Is Progyny, Inc. a good investment? Progyny, Inc. (PGNY) is currently trading at 16.60 USD. Market analysts have a consensus price target of 27.45 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 25.54. This valuation is generally in line with the broader market.

Earnings Schedule: Progyny, Inc. is expected to release its next earnings report on May 6, 2026. The market consensus estimate for Forward EPS is 2.10.

Investor FAQ

Does Progyny, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Progyny, Inc.?

Progyny, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 6, 2026. The company currently has a trailing EPS of 0.65.

Company Profile

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Exchange Ticker
NMS (United States) PGNY

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion